HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples